Ensoma ApS: Financial statements 2023
CVR: 40804307
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Ensoma ApS (CVR 40804307) has filed annual accounts for 2023. In 2023, the company reported a gross profit of EUR -1,954,828 and a net result of EUR -3,141,286 compared with EUR -2,913,603 the year before. Equity in the 2023 report amounted to EUR 1,501,968. The solvency ratio was 67.8%. The company had 15 employees in the financial year.
- Gross Profit
- EUR -1,954,828
- Profit/Loss
- EUR -3,141,286
- Equity
- EUR 1,501,968
- Total Assets
- EUR 2,216,904
- Employees
- 15
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -2M EUR | -3.1M EUR | 1.5M EUR | 15 |
| 2022 | - | -2.1M EUR | -2.9M EUR | -534K EUR | 11 |
| 2021 | - | -1.3M EUR | -1.8M EUR | 2.4M EUR | 10 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Ensoma ApS has published its annual report for 2022. Gross profit came to DKK -2,077,706, and the net result was DKK -2,913,603.
On February 21, 2023, the company changed its name from Twelve Bio ApS to Ensoma ApS.
As of February 8, 2023, Emile Fuad Nuwaysir has joined the board of directors of Ensoma ApS.
As of February 8, 2023, Min Wang has joined the board of directors of Ensoma ApS.
As of February 8, 2023, Guillermo Montoya Blanco has left the board of directors of Ensoma ApS.
As of February 8, 2023, Stefano Stella has left the board of directors of Ensoma ApS.
As of February 8, 2023, Gita Padmavathy Dittmar has left the board of directors of Ensoma ApS.
As of February 8, 2023, Mark David Chin has left the board of directors of Ensoma ApS.
As of February 8, 2023, is registered as an owner of Ensoma ApS with an ownership share of 100%.
About Ensoma ApS
Ensoma ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Twelve Bio ApS and GEBAMO ApS. The management consists of Magnus Glissmann Bojer-Larsen. The board consists of James William Burns (chair), Anders Anton Maier and Chapman McCann Wright. The company is owned by ENSOMA, INC.. The company has 2 employees (2025). In 2025, the company reported a gross profit of EUR -834,944 and a net result of EUR -1,154,216 compared with EUR -5,422,815 the year before. Equity in the 2025 report amounted to EUR 911,971.